← Study Library
Review · 2001
Preclinicalcounts toward this tierVascular mechanisms in osteoarthritis
Ghosh P, Cheras PA · Best Practice & Research. Clinical Rheumatology
Preclinicalcounts toward this tier
The argument that gives an anticoagulant a reason to be an arthritis drug: cartilage-derived antigens provoke synovitis, whose pro-coagulant mediators tip subchondral vessels toward hypercoagulation, hypofibrinolysis and ischaemic bone necrosis — from which the authors predict that agents that are simultaneously antithrombotic, lipid-lowering and anti-inflammatory should slow OA.
- Population
- Narrative review of subchondral vascular pathology in osteoarthritis
- Intervention
- n/a
- Comparator
- n/a
- Limitations
- A hypothesis paper by PPS's developer, arguing for the drug class he developed; the vascular model remains the least directly tested leg of the mechanism, and the trial designed to test it in humans — MaRVeL, which enrols only people with dyslipidaemia — has not reported.
Cited by
1 entry references this study
- Pentosan polysulfate (PPS)PROM.
Peptides → Clinically studied